MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Pogledi
• 07/02/23
0
0
Ugraditi
administrator
Pretplatnici
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari